Han-Ting Zhang Selected Research

diethylstilbestrol monophosphate (PDES)

10/2021	Advances in Cyclic Nucleotide Phosphodiesterase-Targeted PET Imaging and Drug Discovery.
1/2018	Cyclic nucleotide phosphodiesterases: potential therapeutic targets for alcohol use disorder.
1/2017	The Role of Phosphodiesterase-2 in Psychiatric and Neurodegenerative Disorders.
1/2017	Targeting Phosphodiesterases in Pharmacotherapy for Substance Dependence.
1/2015	Phosphodiesterase: an interface connecting cognitive deficits to neuropsychiatric and neurodegenerative diseases.
1/2015	Targeting phosphodiesterases (PDEs) for treatment of CNS diseases.
8/2014	Mice deficient in phosphodiesterase-4A display anxiogenic-like behavior.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Han-Ting Zhang Research Topics

Disease

21	Memory Disorders (Memory Loss) 03/2022 - 08/2004
18	Alzheimer Disease (Alzheimer's Disease) 06/2022 - 07/2009
14	Cognitive Dysfunction 06/2022 - 09/2008
8	Neurodegenerative Diseases (Neurodegenerative Disease) 10/2021 - 02/2013
7	Alcoholism (Alcohol Abuse) 01/2020 - 11/2011
6	Vomiting 12/2020 - 01/2009
4	Central Nervous System Diseases (CNS Diseases) 03/2021 - 01/2015
4	Neuroinflammatory Diseases 01/2020 - 07/2012
3	Brain Injuries (Brain Injury) 03/2021 - 09/2006
3	Ischemia 03/2021 - 09/2006
3	Inflammation (Inflammations) 01/2019 - 07/2012
3	Mental Disorders (Mental Disorder) 01/2017 - 12/2012
2	Mitochondrial Diseases (Mitochondrial Disease) 06/2022 - 03/2022
2	Neuralgia (Stump Neuralgia) 01/2022 - 03/2021
2	Neoplasms (Cancer) 10/2021 - 09/2008
2	Chronic Obstructive Pulmonary Disease (COPD) 10/2021 - 08/2017
2	Reperfusion Injury 03/2021 - 09/2006
2	Stroke (Strokes) 01/2020 - 09/2006
2	Atrophy 11/2019 - 01/2017
2	Thrombosis (Thrombus) 09/2019 - 04/2016
2	Substance-Related Disorders (Drug Abuse) 01/2017 - 01/2015
2	Mood Disorders (Mood Disorder) 01/2017 - 01/2015
2	Depressive Disorder (Melancholia) 02/2013 - 01/2009
2	Brain Ischemia (Cerebral Ischemia) 12/2012 - 03/2011
1	Hypersensitivity (Allergy) 01/2022
1	Pain (Aches) 01/2022
1	Chronic Pain 01/2022
1	Coronary Artery Disease (Coronary Atherosclerosis) 10/2021
1	Transient Ischemic Attack 05/2021
1	Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune) 05/2021
1	Ischemic Stroke 05/2021
1	Parkinson Disease (Parkinson's Disease) 03/2021
1	Subarachnoid Hemorrhage (Aneurysmal Subarachnoid Hemorrhage) 03/2021
1	Nervous System Diseases (Neurological Disorders) 03/2021
1	B-Cell Lymphoma (Lymphoma, B Cell) 12/2020
1	Wounds and Injuries (Trauma) 12/2020
1	Fatigue 01/2020
1	Multiple Sclerosis 11/2019
1	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 01/2019
1	Brain Diseases (Brain Disorder) 01/2019
1	Fragile X Syndrome (Martin Bell Syndrome) 01/2019
1	Astrocytoma (Pilocytic Astrocytoma) 11/2018
1	Genetic Predisposition to Disease (Genetic Predisposition) 01/2018
1	Hemorrhage 04/2016

Drug/Important Bio-Agent (IBA)

14	Type 4 Cyclic Nucleotide PhosphodiesterasesIBA 01/2022 - 08/2004
12	Phosphodiesterase 4 InhibitorsIBA 01/2022 - 01/2009
7	diethylstilbestrol monophosphate (PDES)IBA 10/2021 - 08/2014
7	Peptides (Polypeptides)IBA 01/2020 - 10/2010
7	Phosphoric Diester Hydrolases (Phosphodiesterases)IBA 01/2018 - 01/2011
6	Amyloid (Amyloid Fibrils)IBA 03/2022 - 10/2010
5	fasudil (AT 877)IBA 01/2022 - 01/2018
5	RolipramIBA 01/2022 - 01/2011
5	Cyclic AMP (AMP, Cyclic)IBA 01/2018 - 10/2010
5	EnzymesIBA 08/2017 - 08/2004
4	Pharmaceutical PreparationsIBA 01/2021 - 06/2013
3	RoflumilastIBA 01/2022 - 08/2017
3	BPN14770IBA 11/2019 - 10/2018
3	Ethanol (Ethyl Alcohol)IBA 08/2018 - 11/2011
3	Cyclic NucleotidesIBA 01/2018 - 08/2014
3	Proteins (Proteins, Gene)FDA Link 01/2015 - 01/2013
2	Estrogens (Estrogen)FDA Link 06/2022 - 01/2021
2	biochanin AIBA 06/2022 - 01/2021
2	rho-Associated KinasesIBA 01/2021 - 01/2019
2	Protein Isoforms (Isoforms)IBA 09/2013 - 02/2013
2	Adrenergic Receptors (Adrenergic Receptor)IBA 02/2013 - 01/2011
2	Antidepressive Agents (Antidepressants)IBA 02/2013 - 01/2009
1	baicalinIBA 03/2022
1	ConnexinsIBA 01/2022
1	Connexin 43 (Connexin43)IBA 01/2022
1	Inosine Triphosphate (ITP)IBA 05/2021
1	Therapeutic UsesIBA 01/2021
1	Phytoestrogens (Phytoestrogen)IBA 01/2021
1	Type 7 Cyclic Nucleotide PhosphodiesterasesIBA 01/2021
1	Biotin (Vitamin H)FDA Link 12/2020
1	DNA Nucleotidylexotransferase (Terminal Deoxynucleotidyl Transferase)IBA 12/2020
1	Eosine Yellowish-(YS) (Eosin)IBA 12/2020
1	Hematoxylin (Haematoxylon)IBA 12/2020
1	bcl-2-Associated X Protein (bcl 2 Associated X Protein)IBA 12/2020
1	Huang QiIBA 01/2020
1	gamma-Aminobutyric Acid (GABA)IBA 01/2020
1	Aminobutyrates (Aminobutyric Acid)IBA 01/2020
1	Folic Acid (Vitamin M)FDA LinkGeneric 11/2019
1	HomocysteineIBA 11/2019
1	N- (2- (4- bromocinnamylamino)ethyl)- 5- isoquinolinesulfonamide (h89)IBA 11/2019
1	Cyclic AMP-Dependent Protein Kinases (cAMP-Dependent Protein Kinase)IBA 11/2019
1	Vitamin B 12 (Cyanocobalamin)FDA LinkGeneric 11/2019
1	HydrogenIBA 09/2019
1	Malondialdehyde (Propanedial)IBA 09/2019
1	CytokinesIBA 11/2018
1	Interleukin-6 (Interleukin 6)IBA 11/2018
1	gingerolIBA 11/2018
1	Cyclic GMPIBA 01/2018
1	Cyclin-Dependent Kinase 5IBA 01/2017
1	ResveratrolIBA 04/2016
1	Amyloid beta-PeptidesIBA 04/2016

Therapy/Procedure

7	Therapeutics 03/2021 - 02/2013
7	Drug Therapy (Chemotherapy) 01/2020 - 09/2008
2	Anesthesia 03/2021 - 01/2011
1	Ligation 01/2022
1	Oral Administration 04/2016